메뉴 건너뛰기




Volumn 136, Issue 4, 2011, Pages 578-586

Evaluation of HPV-16 and HPV-18 genotyping for the triage of women with high-risk HPV+ cytology-negative results

(72)  Wright Jr , Thomas C a   Stoler, Mark H b   Sharma, Abha c   Zhang, Guili c   Behrens, Catherine c   Wright, Teresa L c   Ferenczy, Alexander d   Body, B A e   Butcher, A c   Eisenhut, C f   Rao, A g   Young, S h   Ackerman, R i   Anders, R j   Andruczyk, E k   Aqua, K l   Black, R m   Blank, S n   Bressman, P o   Brody, K p   more..


Author keywords

Adjunct testing; Cervical cancer screening; Cervical intraepithelial neoplasia; Cytology; Genotype; HPV DNA testing; Negative for intraepithelial lesions or malignancy; NILM

Indexed keywords

ADULT; AGED; ARTICLE; BIOPSY TECHNIQUE; CANCER RISK; COLPOSCOPY; EMERGENCY HEALTH SERVICE; FEMALE; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; MAJOR CLINICAL STUDY; NONHUMAN; PAPILLOMAVIRUS INFECTION; PREVALENCE; PRIORITY JOURNAL; SCREENING TEST; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY;

EID: 80053473495     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCPTUS5EXAS6DKZ     Document Type: Article
Times cited : (201)

References (29)
  • 2
    • 34548497655 scopus 로고    scopus 로고
    • Human papillomavirus and cervical cancer
    • DOI 10.1016/S0140-6736(07)61416-0, PII S0140673607614160
    • Schiffman M, Castle PE, Jeronimo J, et al. Human papillomavirus and cervical cancer. Lancet. 2007;370:890-907. (Pubitemid 47371147)
    • (2007) Lancet , vol.370 , Issue.9590 , pp. 890-907
    • Schiffman, M.1    Castle, P.E.2    Jeronimo, J.3    Rodriguez, A.C.4    Wacholder, S.5
  • 4
    • 77953705396 scopus 로고    scopus 로고
    • Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone: What screening intervals are physicians recommending?
    • Saraiya M, Berkowitz Z, Yabroff KR, et al. Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone: what screening intervals are physicians recommending? Arch Intern Med. 2010;170:977-985.
    • (2010) Arch Intern Med , vol.170 , pp. 977-985
    • Saraiya, M.1    Berkowitz, Z.2    Yabroff, K.R.3
  • 5
    • 34548161126 scopus 로고    scopus 로고
    • Cervical cancer screening and management practices among providers in the National Breast and Cervical Cancer Early Detection Program (NBCCEDP)
    • DOI 10.1002/cncr.22875
    • Saraiya M, Irwin KL, Carlin L, et al. Cervical cancer screening and management practices among providers in the National Breast and Cervical Cancer Early Detection Program (NBCCEDP). Cancer. 2007;110:1024-1032. (Pubitemid 47312868)
    • (2007) Cancer , vol.110 , Issue.5 , pp. 1024-1032
    • Saraiya, M.1    Irwin, K.L.2    Carlin, L.3    Chen, X.4    Jain, N.5    Benard, V.6    Montano, D.E.7
  • 6
    • 0142062150 scopus 로고    scopus 로고
    • Chapter 1: Human papillomavirus and cervical cancer: Burden and assessment of causality
    • Bosch FX, De Sanjose S. Chapter 1: Human papillomavirus and cervical cancer: burden and assessment of causality. J Natl Cancer Inst Monogr. 2003:3-13.
    • (2003) J Natl Cancer Inst Monogr , pp. 3-13
    • Bosch, F.X.1    De Sanjose, S.2
  • 7
    • 34250736244 scopus 로고    scopus 로고
    • Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: A meta-analysis
    • DOI 10.1016/S1473-3099(07)70158-5, PII S1473309907701585
    • De Sanjose S, Diaz M, Castellsague X, et al. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis. 2007;7:453-459. (Pubitemid 46962343)
    • (2007) Lancet Infectious Diseases , vol.7 , Issue.7 , pp. 453-459
    • De Sanjose, S.1    Diaz, M.2    Castellsague, X.3    Clifford, G.4    Bruni, L.5    Munoz, N.6    Bosch, F.X.7
  • 9
    • 79954434168 scopus 로고    scopus 로고
    • High-risk human papillomavirus testing in women with ASC-US cytology: Results from the ATHENA HPV study
    • Stoler MH, Wright TC Jr, Sharma A, et al. High-risk human papillomavirus testing in women with ASC-US cytology: results from the ATHENA HPV study. Am J Clin Pathol. 2011;135:468-475.
    • (2011) Am J Clin Pathol , vol.135 , pp. 468-475
    • Stoler, M.H.1    Wright Jr., T.C.2    Sharma, A.3
  • 13
    • 80053473617 scopus 로고    scopus 로고
    • Pleasanton, CA: Roche Molecular Systems
    • cobas HPV Test [package insert]. Pleasanton, CA: Roche Molecular Systems; 2009.
    • (2009) Cobas HPV Test [Package Insert]
  • 15
    • 26944460457 scopus 로고    scopus 로고
    • The probability for a Pap test to be abnormal is directly proportional to HPV viral load: Results from a Swiss study comparing HPV testing and liquid-based cytology to detect cervical cancer precursors in 13 842 women
    • DOI 10.1038/sj.bjc.6602728, PII 6602728
    • Bigras G, De Marval F. The probability for a Pap test to be abnormal is directly proportional to HPV viral load: results from a Swiss study comparing HPV testing and liquid-based cytology to detect cervical cancer precursors in 13,842 women. Br J Cancer. 2005;93:575-581. (Pubitemid 43080002)
    • (2005) British Journal of Cancer , vol.93 , Issue.5 , pp. 575-581
    • Bigras, G.1    De Marval, F.2
  • 18
    • 55549122325 scopus 로고    scopus 로고
    • Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: Joint European cohort study
    • doi:10.1136/bmj.a1754
    • Dillner J, Rebolj M, Birembaut P, et al. Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study. BMJ. 2008;337:a1754. doi:10.1136/bmj.a1754.
    • (2008) BMJ , vol.337
    • Dillner, J.1    Rebolj, M.2    Birembaut, P.3
  • 19
    • 79952993791 scopus 로고    scopus 로고
    • A comparison of HPV DNA testing and liquid based cytology over three rounds of primary cervical screening: Extended follow up in the ARTISTIC trial
    • published online ahead of print February 18, doi:10.1016/j.ejca.2011.01. 008
    • Kitchener HC, Gilham C, Sargent A, et al. A comparison of HPV DNA testing and liquid based cytology over three rounds of primary cervical screening: extended follow up in the ARTISTIC trial [published online ahead of print February 18, 2011]. Eur J Cancer. doi:10.1016/j.ejca.2011.01.008.
    • (2011) Eur J Cancer
    • Kitchener, H.C.1    Gilham, C.2    Sargent, A.3
  • 20
    • 77957835319 scopus 로고    scopus 로고
    • Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: Role of persistence
    • Kjaer SK, Frederiksen K, Munk C, et al. Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence. J Natl Cancer Inst. 2010;102:1478-1488.
    • (2010) J Natl Cancer Inst , vol.102 , pp. 1478-1488
    • Kjaer, S.K.1    Frederiksen, K.2    Munk, C.3
  • 21
    • 33748142054 scopus 로고    scopus 로고
    • Chapter 5: Updating the natural history of HPV and anogenital cancer
    • Moscicki AM, Schiffman M, Kjaer S, et al. Chapter 5: Updating the natural history of HPV and anogenital cancer. Vaccine. 2006;24(suppl 3):S3/42-S3/51.
    • (2006) Vaccine , vol.24 , Issue.SUPPL. 3
    • Moscicki, A.M.1    Schiffman, M.2    Kjaer, S.3
  • 22
    • 85058205581 scopus 로고    scopus 로고
    • The ATHENA human papillomavirus study: Design, methods, and baseline results
    • In press
    • Wright TC Jr, Stoler MH, Behrens CM, et al. The ATHENA human papillomavirus study: design, methods, and baseline results. Am J Obstet Gynecol. In press.
    • Am J Obstet Gynecol
    • Wright Jr., T.C.1    Stoler, M.H.2    Behrens, C.M.3
  • 25
    • 0037048697 scopus 로고    scopus 로고
    • Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: Comparison of sensitivity, specificity, and frequency of referral
    • Kulasingam SL, Hughes JP, Kiviat NB, et al. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral. JAMA. 2002;288:1749-1757.
    • (2002) JAMA , vol.288 , pp. 1749-1757
    • Kulasingam, S.L.1    Hughes, J.P.2    Kiviat, N.B.3
  • 27
    • 0035970728 scopus 로고    scopus 로고
    • Estimating prevalence when the true disease status is incompletely ascertained
    • DOI 10.1002/sim.907
    • Sasieni P. Estimating prevalence when the true disease status is incompletely ascertained. Stat Med. 2001;20:935-949. (Pubitemid 32249091)
    • (2001) Statistics in Medicine , vol.20 , Issue.6 , pp. 935-949
    • Sasieni, P.1
  • 28
    • 1442305204 scopus 로고    scopus 로고
    • Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening
    • Wright TC Jr, Schiffman M, Solomon D, et al. Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening. Obstet Gynecol. 2004;103:304-309.
    • (2004) Obstet Gynecol , vol.103 , pp. 304-309
    • Wright Jr., T.C.1    Schiffman, M.2    Solomon, D.3
  • 29
    • 34848877480 scopus 로고    scopus 로고
    • Risk assessment to guide the prevention of cervical cancer
    • doi:10.1016/j.ajog.2007.07.049
    • Castle PE, Sideri M, Jeronimo J, et al. Risk assessment to guide the prevention of cervical cancer. Am J Obstet Gynecol. 2007;197:356.e1-356.e6. doi:10.1016/j.ajog.2007.07.049.
    • (2007) Am J Obstet Gynecol , vol.197
    • Castle, P.E.1    Sideri, M.2    Jeronimo, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.